Chan CL - Search Results

1

Risk factors for contact lens-related fusarium keratitis: a case-control study in Singapore.

Saw SM, Ooi PL, Tan DT, Khor WB, Fong CW, Lim J, Cajucom-Uy HY, Heng D, Chew SK, Aung T, Tan AL, Chan CL, Ting S, Tambyah PA, Wong TY. Saw SM, et al. Among authors: chan cl. Arch Ophthalmol. 2007 May;125(5):611-7. doi: 10.1001/archopht.125.5.611. Arch Ophthalmol. 2007. PMID: 17502498

2

Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study.

Toh DS, Tan LL, Aw DC, Pang SM, Lim SH, Thirumoorthy T, Lee HY, Tay YK, Tan SK, Vasudevan A, Lateef A, Chong YY, Chan YC, Loke C, Chan CL, Koay ES, Ren EC, Lee EJ, Sung C. Toh DS, et al. Among authors: chan yc, chan cl. Pharmacogenomics J. 2014 Aug;14(4):316-21. doi: 10.1038/tpj.2013.46. Epub 2014 Jan 7. Pharmacogenomics J. 2014. PMID: 24394201

3

Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009.

Patel DN, Low WL, Tan LL, Tan MM, Zhang Q, Low MY, Chan CL, Koh HL. Patel DN, et al. Among authors: chan cl. Clin Toxicol (Phila). 2012 Jul;50(6):481-9. doi: 10.3109/15563650.2012.700402. Epub 2012 Jun 27. Clin Toxicol (Phila). 2012. PMID: 22738039

4

Data mining spontaneous adverse drug event reports for safety signals in Singapore - a comparison of three different disproportionality measures.

Ang PS, Chen Z, Chan CL, Tai BC. Ang PS, et al. Among authors: chan cl. Expert Opin Drug Saf. 2016 May;15(5):583-90. doi: 10.1517/14740338.2016.1167184. Epub 2016 Apr 7. Expert Opin Drug Saf. 2016. PMID: 26996192

5

Introduction to risk management plans in the Singapore context.

Ho CSC, Tan LLB, Chan CL. Ho CSC, et al. Among authors: chan cl. Singapore Med J. 2019 Sep;60(9):483-486. doi: 10.11622/smedj.2019111. Singapore Med J. 2019. PMID: 31570951 Free PMC article.

6

Detecting Signals of Disproportionate Reporting from Singapore's Spontaneous Adverse Event Reporting System: An Application of the Sequential Probability Ratio Test.

Chan CL, Rudrappa S, Ang PS, Li SC, Evans SJW. Chan CL, et al. Drug Saf. 2017 Aug;40(8):703-713. doi: 10.1007/s40264-017-0531-4. Drug Saf. 2017. PMID: 28455793

7

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting.

Yap J, Tham MY, Poh J, Toh D, Chan CL, Lim TW, Lim SL, Chia YW, Lim YT, Choo J, Ding ZP, Foo LL, Kuo S, Lau YH, Lee A, Yeo KK. Yap J, et al. Among authors: chan cl. Ann Acad Med Singap. 2022 Feb;51(2):96-100. doi: 10.47102/annals-acadmedsg.2021425. Ann Acad Med Singap. 2022. PMID: 35224605 Free article.

8

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.

Tan-Koi WC, Sung C, Chong YY, Lateef A, Pang SM, Vasudevan A, Aw D, Lui NL, Lee SX, Ren EC, Koay ES, Tay YK, Lim YL, Lee HY, Dong D, Loke C, Tan L, Limenta M, Lee EJ, Toh D, Chan CL. Tan-Koi WC, et al. Among authors: chan cl. Pharmacogenomics. 2017 Jun;18(9):881-890. doi: 10.2217/pgs-2017-0016. Epub 2017 Jun 8. Pharmacogenomics. 2017. PMID: 28594314

9

Quantitative data mining in signal detection: the Singapore experience.

Chan CL, Soh S, Tan SH, Ang PS, Rudrappa S, Li SC, Evans SJW. Chan CL, et al. Expert Opin Drug Saf. 2020 May;19(5):633-639. doi: 10.1080/14740338.2020.1734559. Epub 2020 Mar 2. Expert Opin Drug Saf. 2020. PMID: 32092284

10

Global Challenges in Regulatory Capacity and Capability Building: Extrapolating Lessons Learned From the HSA.

Lim JCW, Chan CL, Green A. Lim JCW, et al. Among authors: chan cl. Clin Pharmacol Ther. 2019 Apr;105(4):805-808. doi: 10.1002/cpt.1253. Epub 2018 Nov 20. Clin Pharmacol Ther. 2019. PMID: 30460683 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

672 results

Search Page